Logo image of ALMKS.PA

MAKING SCIENCE GROUP SA (ALMKS.PA) Stock Fundamental Analysis

EPA:ALMKS - Euronext Paris - Matif - ES0105463006 - Common Stock - Currency: EUR

9.05  0 (0%)

Fundamental Rating

3

Overall ALMKS gets a fundamental rating of 3 out of 10. We evaluated ALMKS against 63 industry peers in the Media industry. ALMKS has a bad profitability rating. Also its financial health evaluation is rather negative. ALMKS is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALMKS had negative earnings in the past year.
In the past year ALMKS had a positive cash flow from operations.
ALMKS had negative earnings in 4 of the past 5 years.
Of the past 5 years ALMKS 4 years had a positive operating cash flow.
ALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

ALMKS has a worse Return On Assets (-1.00%) than 77.78% of its industry peers.
ALMKS has a Return On Equity of -6.68%. This is in the lower half of the industry: ALMKS underperforms 77.78% of its industry peers.
ALMKS has a Return On Invested Capital of 7.61%. This is in the better half of the industry: ALMKS outperforms 68.25% of its industry peers.
Industry RankSector Rank
ROA -1%
ROE -6.68%
ROIC 7.61%
ROA(3y)-2.48%
ROA(5y)-1.44%
ROE(3y)-22.79%
ROE(5y)-9.81%
ROIC(3y)N/A
ROIC(5y)N/A
ALMKS.PA Yearly ROA, ROE, ROICALMKS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

ALMKS has a Operating Margin of 1.87%. This is in the lower half of the industry: ALMKS underperforms 66.67% of its industry peers.
In the last couple of years the Operating Margin of ALMKS has declined.
ALMKS has a Gross Margin of 20.49%. This is amonst the worse of the industry: ALMKS underperforms 82.54% of its industry peers.
ALMKS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.87%
PM (TTM) N/A
GM 20.49%
OM growth 3YN/A
OM growth 5Y-6.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.38%
GM growth 5Y-5.28%
ALMKS.PA Yearly Profit, Operating, Gross MarginsALMKS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

2

2. Health

2.1 Basic Checks

ALMKS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ALMKS has been increased compared to 1 year ago.
Compared to 5 years ago, ALMKS has more shares outstanding
ALMKS has a better debt/assets ratio than last year.
ALMKS.PA Yearly Shares OutstandingALMKS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALMKS.PA Yearly Total Debt VS Total AssetsALMKS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ALMKS has an Altman-Z score of 1.75. This is a bad value and indicates that ALMKS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.75, ALMKS perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
ALMKS has a debt to FCF ratio of 1126.96. This is a negative value and a sign of low solvency as ALMKS would need 1126.96 years to pay back of all of its debts.
ALMKS's Debt to FCF ratio of 1126.96 is on the low side compared to the rest of the industry. ALMKS is outperformed by 74.60% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that ALMKS is not too dependend on debt financing.
ALMKS has a Debt to Equity ratio of 0.47. This is comparable to the rest of the industry: ALMKS outperforms 55.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1126.96
Altman-Z 1.75
ROIC/WACC1.11
WACC6.88%
ALMKS.PA Yearly LT Debt VS Equity VS FCFALMKS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

ALMKS has a Current Ratio of 0.75. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.75, ALMKS is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
A Quick Ratio of 0.73 indicates that ALMKS may have some problems paying its short term obligations.
The Quick ratio of ALMKS (0.73) is worse than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.73
ALMKS.PA Yearly Current Assets VS Current LiabilitesALMKS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.02% over the past year.
The Revenue has grown by 16.03% in the past year. This is quite good.
Measured over the past years, ALMKS shows a very strong growth in Revenue. The Revenue has been growing by 51.21% on average per year.
EPS 1Y (TTM)63.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-319.11%
Revenue 1Y (TTM)16.03%
Revenue growth 3Y35.32%
Revenue growth 5Y51.21%
Sales Q2Q%21.07%

3.2 Future

Based on estimates for the next years, ALMKS will show a very strong growth in Earnings Per Share. The EPS will grow by 64.22% on average per year.
The Revenue is expected to grow by 20.54% on average over the next years. This is a very strong growth
EPS Next Y106.06%
EPS Next 2Y64.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.09%
Revenue Next 2Y20.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALMKS.PA Yearly Revenue VS EstimatesALMKS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ALMKS.PA Yearly EPS VS EstimatesALMKS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMKS. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 13.05 indicates a correct valuation of ALMKS.
ALMKS's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of ALMKS to the average of the S&P500 Index (22.19), we can say ALMKS is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 13.05
ALMKS.PA Price Earnings VS Forward Price EarningsALMKS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

66.67% of the companies in the same industry are cheaper than ALMKS, based on the Enterprise Value to EBITDA ratio.
74.60% of the companies in the same industry are cheaper than ALMKS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1618.9
EV/EBITDA 9.75
ALMKS.PA Per share dataALMKS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALMKS's earnings are expected to grow with 64.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.22%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALMKS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAKING SCIENCE GROUP SA

EPA:ALMKS (6/20/2025, 7:00:00 PM)

9.05

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.56%
Inst Owner ChangeN/A
Ins Owners63.56%
Ins Owner ChangeN/A
Market Cap81.27M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)12.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.05
P/S 0.3
P/FCF 1618.9
P/OCF 249.37
P/B 3.16
P/tB N/A
EV/EBITDA 9.75
EPS(TTM)-0.19
EYN/A
EPS(NY)0.69
Fwd EY7.66%
FCF(TTM)0.01
FCFY0.06%
OCF(TTM)0.04
OCFY0.4%
SpS30.46
BVpS2.87
TBVpS-4.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1%
ROE -6.68%
ROCE 10.35%
ROIC 7.61%
ROICexc 13.76%
ROICexgc N/A
OM 1.87%
PM (TTM) N/A
GM 20.49%
FCFM 0.02%
ROA(3y)-2.48%
ROA(5y)-1.44%
ROE(3y)-22.79%
ROE(5y)-9.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-6.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.38%
GM growth 5Y-5.28%
F-Score6
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1126.96
Debt/EBITDA 1.05
Cap/Depr 4.23%
Cap/Sales 0.1%
Interest Coverage 1.14
Cash Conversion 2.8%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.73
Altman-Z 1.75
F-Score6
WACC6.88%
ROIC/WACC1.11
Cap/Depr(3y)13.72%
Cap/Depr(5y)311.76%
Cap/Sales(3y)0.4%
Cap/Sales(5y)7.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-319.11%
EPS Next Y106.06%
EPS Next 2Y64.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.03%
Revenue growth 3Y35.32%
Revenue growth 5Y51.21%
Sales Q2Q%21.07%
Revenue Next Year24.09%
Revenue Next 2Y20.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y279.3%
EBIT growth 3YN/A
EBIT growth 5Y41.57%
EBIT Next Year207.02%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y103.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y177.63%
OCF growth 3Y-64.38%
OCF growth 5YN/A